The situation is more complex in colon cancer where frequent co-occurrence of KRAS and PIK3CA mutations and a lack of concordance between levels of PI3K pathway activation and oncogenic K-Ras suppression are observed32, 33. This evidence concerns the gene KRAS and colonic neoplasm.